Clarivate

OCTOBER 25, 2023

Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e., How the IRA could affect treatment choice While price negotiations are intended to lower Medicare costs, they also present a challenge to physician practice economics.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Medgadget

MARCH 2, 2023

Moreover, due to the different nature of healthy and cancerous tissue, alpha radiation produced by Alpha DaRT sources diffuses about a millimeter into healthy tissue while penetrating at a diameter up to about five millimeters into tumors, providing an automatic safety mechanism.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

Clarivate

MAY 24, 2022

Approval pathways have been established that allow manufacturers to bring innovative therapies to market without conducting trials in Mainland China, provided the safety and efficacy of the drugs have been demonstrated through real world data (RWD) in other markets. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Clarivate

OCTOBER 10, 2022

Fruquintinib was well-tolerated, with a safety profile consistent with that previously reported in other studies. The question of which KRAS inhibitor is most effective remains elusive, although being first to market in addition to strong efficacy and safety data could differentiate the more competitive agent. Market impact.

Marketing 52

Marketing Safety Patients Competition 52

Clarivate

OCTOBER 7, 2021

What’s new from ESMO: Interim efficacy and safety analysis from the randomized KEYNOTE-716 study showed that the trial met its primary endpoint of RFS, with patients receiving Keytruda presenting an RFS of 90.5% Kisqali plus letrozole demonstrated a significant OS benefit, but is that enough to displace physician favorite Ibrance?

Patients 91

Patients Safety Marketing Physicians 91

PM360

JUNE 24, 2024

For example, a biopharma may want to track the improvement in patient adherence to a therapy pre- and post-launch of a PSP across regions to gauge its impact. 2,3 A well-designed PSP provides data to support the improvement of patient care and demonstrates the value of a product beyond the standard efficacy and safety measures.

Patients 118

Patients Education Healthcare Healthcare 118

Clarivate

DECEMBER 1, 2021

Treatment cost and compliance are key factors in sustaining effective long-term disease management, a powerful new oral option could be more widely accepted than the injectable competition and rapidly gain traction in the market, especially among primary care physicians. Contributors. Circulation 2021; 144(suppl1): LBS.05. Perin EC, et al.

Patients 52

Patients Safety Management Marketing 52

PM360

DECEMBER 14, 2023

“We’re now leveraging our expertise in communicating with healthcare professionals to deliver essential information and practical tools to physicians and other healthcare providers to help them address the challenges faced by patients with chronic illness.”

Physicians 52

Physicians Pharma Medical Patients 52